Approvals/TGA/JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack

Approved

STANDARD

JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3fa2970615fc47a0
Product Name: JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack
Artg Id: 408437
Artg Name: JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2023-08-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9c921d8d7d6bcee3764f852eedbc0ea6.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/38ad6a2d22142a1297fef6d60e490778.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

3fa2970615fc47a0

Type

Standard